CLINICAL_TRIALS
trial_result
· 2012-03-29
Clinical Trial Update: A Phase II Study of Paclitaxel and Carboplatin in Patients With an Elevated-Risk Cancer of the Uterus [Phase 2]
Summary
A Phase II trial evaluating paclitaxel and carboplatin in elevated-risk endometrial cancer was terminated; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Alabama at Birmingham | Conditions: Uterine Cancer | Phase 2 | Status: TERMINATED | Results posted: 2012-03-29